Bayesian Capital Management, LP Schrodinger, Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.62 - $37.21 $177,284 - $305,122	8,200 New	8,200 $293,000
Q2 2023 Aug 14, 2023	SELL	$26.1 - $49.92 $138,330 - $264,576	-5,300 Reduced 51.5%	4,991 $249,000
Q1 2023 May 15, 2023	BUY	$18.09 - $27.61 $186,164 - $284,134	10,291 New	10,291 $270,000
Q2 2022 Aug 15, 2022	SELL	$21.39 - $35.9 $573,252 - $962,120	-26,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$24.84 - $36.12 $665,712 - $968,015	26,800 New	26,800 $914,000

235

60.7M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.23B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.